These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10. Langsjoen PH, Vadhanavikit S, Folkers K. Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4240-4. PubMed ID: 3858877 [Abstract] [Full Text] [Related]
31. Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure. Mortensen SA, Vadhanavikit S, Baandrup U, Folkers K. Drugs Exp Clin Res; 1985 Mar; 11(8):581-93. PubMed ID: 3836876 [Abstract] [Full Text] [Related]
33. The clinical and hemodynamic effects of coenzyme Q10 in congestive cardiomyopathy. Sacher HL, Sacher ML, Landau SW, Kersten R, Dooley F, Sacher A, Sacher M, Dietrick K, Ichkhan K. Am J Ther; 1997 Mar; 4(2-3):66-72. PubMed ID: 10423594 [Abstract] [Full Text] [Related]
34. Myocardial preservation by therapy with coenzyme Q10 during heart surgery. Judy WV, Stogsdill WW, Folkers K. Clin Investig; 1993 Mar; 71(8 Suppl):S155-61. PubMed ID: 8241702 [Abstract] [Full Text] [Related]
35. Recovery of the Frank-Starling mechanism by coenzyme Q10 in patients with load-induced contractility depression. Oda T. Clin Investig; 1993 Mar; 71(8 Suppl):S150-4. PubMed ID: 8241701 [Abstract] [Full Text] [Related]
36. Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure. Mortensen SA, Vadhanavikit S, Muratsu K, Folkers K. Int J Tissue React; 1990 Mar; 12(3):155-62. PubMed ID: 2276893 [Abstract] [Full Text] [Related]